Latest information on COVID-19
Support teaching, research, and patient care.
Dr. Lee is the chief of vascular surgery for Stanford Medicine. He is a fellowship-trained, board-certified vascular surgeon and a world-renowned leader in the field. He has a strong “patient first” philosophy of care. For every case, he emphasizes the most advanced, minimally invasive diagnostic and treatment approaches. He works closely with a multidisciplinary team of specialists to ensure that each care plan is personalized, precise, compassionate, and comprehensive.Dr. Lee also is passionate about educating and mentoring tomorrow’s vascular surgeons. He is a professor of surgery at Stanford University School of Medicine. He serves as president of the Vascular and Endovascular Surgery Society and in leadership roles for the Society for Clinical Vascular Surgery, National Comprehensive Cancer Network, American Heart Association, and American Board of Surgery.Dr. Lee champions clinical and translational research. His research findings have helped advance minimally invasive endovascular aneurysm repair (EVAR) and other surgical procedures.He has made nearly 600 presentations worldwide, including 200 peer-reviewed abstract presentations at meetings of the Society for Vascular Surgery, American Association for Thoracic Surgery, and other conferences. He has co-authored dozens of book chapters and published more than 160 articles on innovations in the treatment of aortic aneurysms, vascular trauma, deep vein thrombosis, and athletic vascular disorders. His work has appeared in the Journal of Vascular Surgery, Annals of Surgery, JAMA Surgery, and other peer-reviewed journals. Dr. Lee has earned extensive recognition for his achievements. The Vascular and Endovascular Surgery Society, Society for Vascular Surgery, National Institutes of Health, Robert Wood Johnson Foundation, and many other organizations have honored his work.He is a member of the American Surgical Association, Society for Vascular Surgery, International Society of Endovascular Specialists, and other professional societies.
Describe your current research interest and activities
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch
Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the
aortic arch with a proximal landing zone, native or previously implanted surgical graft, in
the ascending aorta and with a brachiocephalic trunk native landing zone.
View full details
Zenith® p-Branch® Endovascular Graft Pivotal Study
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety
and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium
iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation
The purpose of this extended study is to collect confirmatory safety and effectiveness data
on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the
commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac
PRESERVE-Zenith® Iliac Branch System Clinical Study
The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the
safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in
combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the
treatment of aorto-iliac and iliac aneurysms.
Endovascular Repair of Abdominal Aortic Aneurysms
The purpose of this study is to determine if it is safe and effective to use the TALENT AAA
Stent Graft System as a treatment for AAAs in patients who are also candidates for
conventional surgical aneurysm repair.
Stanford is currently not accepting patients for this trial.
For more information, please contact Christopher Zarins, 6507255227.
Endovascular Repair of Descending Thoracic Aortic Aneurysms
The purpose of this study is to determine whether the system is safe and effective for the
intended use of treating descending thoracic aortic aneurysms.
Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms
The purpose of this study is to assess the feasibility of the use of the GORE® TAG® Thoracic
Branch Endoprosthesis to treat aneurysms involving the proximal Descending Thoracic Aorta